Agency Forms Undergoing Paperwork Reduction Act Review, 72867-72868 [2012-29474]
Download as PDF
<![CDATA[
72867
Federal Register / Vol. 77, No. 235 / Thursday, December 6, 2012 / Notices
the use of photographic images, the
ONC invites suggestions for extending
the HL7 DAM to accommodate images.
Ownership of intellectual property is
determined by the following:
• Each entrant retains title and full
ownership in and to their submission.
Entrants expressly reserve all
intellectual property rights not
expressly granted under the challenge
agreement.
• By participating in the challenge,
each entrant hereby irrevocably grants
to Sponsor and Administrator a limited,
non-exclusive, royalty free, worldwide,
license and right to reproduce,
publically perform, publically display,
and use the Submission to the extent
necessary to administer the challenge,
and to publically perform and
publically display the Submission,
including, without limitation, for
advertising and promotional purposes
relating to the challenge.
Authority: 15 U.S.C. 3719.
Dated: November 20, 2012.
Farzad Mostashari,
National Coordinator for Health Information
Technology.
[FR Doc. 2012–29524 Filed 12–5–12; 8:45 am]
BILLING CODE 4150–45–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[30Day–13–0214]
Agency Forms Undergoing Paperwork
Reduction Act Review
The Centers for Disease Control and
Prevention (CDC) publishes a list of
information collection requests under
review by the Office of Management and
Budget (OMB) in compliance with the
Paperwork Reduction Act (44 U.S.C.
Chapter 35). To request a copy of these
requests, call (404) 639–7570 or send an
email to omb@cdc.gov. Send written
comments to CDC Desk Officer, Office of
Management and Budget, Washington,
DC or by fax to (202) 395–5806. Written
comments should be received within 30
days of this notice.
Proposed Project
National Health Interview Survey
(NHIS), (OMB No. 0920–0214 expiration
08/31/2014)—Revision—National
Center for Health Statistics (NCHS),
Centers for Disease Control and
Prevention (CDC).
Background and Brief Description
Section 306 of the Public Health
Service (PHS) Act (42 U.S.C. 242k), as
amended, authorizes that the Secretary
of Health and Human Services (DHHS),
acting through NCHS, shall collect
statistics on the extent and nature of
illness and disability of the population
of the United States.
The annual National Health Interview
Survey is a major source of general
statistics on the health of the U.S.
population and has been in the field
continuously since 1957. Clearance is
sought for three years, to collect data for
2013, 2014, and 2015. This voluntary
household-based survey collects
demographic and health-related
information on a nationally
representative sample of persons and
households throughout the country.
Information is collected using computer
assisted personal interviews (CAPI). A
core set of data is collected each year
while sponsored supplements vary from
year to year. For 2013, there are
supplementary questions on cancer
screening, asthma, immune
suppression, hepatitis, epilepsy, HIV
testing, neighborhood characteristics,
financial worries, sleep issues, and
sexual identity.
Cases in a 5,000 case test were
randomly assigned to receive questions
on HIV testing, neighborhood
characteristics, financial worries, sleep
issues, and sexual identity in either
CAPI or ACASI. Prevalence estimates
for the sexual identity questions were
compared by mode of administration.
Since a documented advantage of
ACASI is the enhanced level of privacy
it affords, we anticipated higher
prevalence estimates from this mode of
administration. Estimates were similar
for the two modes of administration.
Therefore, the questions will be
administered in CAPI, the more cost
efficient mode.
In accordance with the 1995 initiative
to increase the integration of surveys
within the Department of Health and
Human Services, respondents to the
NHIS serve as the sampling frame for
the Medical Expenditure Panel Survey
conducted by the Agency for Healthcare
Research and Quality. The NHIS has
long been used by government,
university, and private researchers to
evaluate both general health and
specific issues, such as cancer, diabetes,
and access to health care. It is a leading
source of data for the Congressionallymandated ‘‘Health US’’ and related
publications, as well as the single most
important source of statistics to track
progress toward the National Health
Promotion and Disease Prevention
Objectives.
There is no cost to the respondents
other than their time. As shown below,
the estimated overall average annual
burden for the 2013, 2014, and 2015
surveys is 57,099 hours.
ANNUALIZED BURDEN TABLE
Number of
respondents
mstockstill on DSK4VPTVN1PROD with
Questionnaire (respondent)
Screener Questionnaire ...............................................................................................................
Family Core (adult family member) .............................................................................................
Adult Core (sample adult) ............................................................................................................
Child Core (adult family member) ...............................................................................................
Child/Teen Record Check (medical provider) .............................................................................
Supplements (adult family member) ............................................................................................
Sexual Identity Module (adult family member) ............................................................................
Multi-mode study (adult family member) .....................................................................................
Reinterview Survey ......................................................................................................................
Sample Frame Test (adult family member) .................................................................................
VerDate Mar<15>2010
16:42 Dec 05, 2012
Jkt 229001
PO 00000
Frm 00055
Fmt 4703
Sfmt 4703
12,000
55,000
44,000
17,000
10,000
60,000
44,000
5,000
5,000
5,000
E:\FR\FM\06DEN1.SGM
06DEN1
Number of
responses per
respondent
1
1
1
1
1
1
1
1
1
1
Average
burden per
respondent
in hours
5/60
23/60
15/60
10/60
5/60
12/60
4/60
30/60
5/60
30/60
72868
Federal Register / Vol. 77, No. 235 / Thursday, December 6, 2012 / Notices
Kimberly S. Lane,
Deputy Director, Office of Scientific Integrity,
Office of the Associate Director for Science,
Office of the Director, Centers for Disease
Control and Prevention.
[FR Doc. 2012–29474 Filed 12–5–12; 8:45 am]
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
The Centers for Disease Control (CDC)/
Health Resources and Services
Administration (HRSA) Advisory
Committee on HIV, Viral Hepatitis and
STD Prevention and Treatment Notice
of Charter Renewal
This gives notice under the Federal
Advisory Committee Act (Pub. L. 92–
463) of October 6, 1972, that the CDC/
HRSA Advisory Committee on HIV,
Viral Hepatitis and STD Prevention and
Treatment, Department of Health and
Human Services, has been renewed for
a 2-year period through November 25,
2014.
Contact Person for More Information:
Kevin Fenton, M.D., Ph.D., Designated
Federal Officer, CDC/HRSA Advisory
Committee on HIV, Viral Hepatitis and
STD Prevention and Treatment,
Department of Health and Human
Services, CDC, 1600 Clifton Road, NE.,
Mailstop E07, Atlanta, Georgia 30333,
telephone (404) 639–8000 or fax (404)
639–8600.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities, for both the
Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Dated: November 29, 2012.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
BILLING CODE 4163–18–P
Centers for Disease Control and
Prevention
Request for Nominations for
Candidates To Serve on the National
Public Health Surveillance and
Biosurveillance Advisory Committee
(NPHSBAC)
BILLING CODE 4163–18–P
[FR Doc. 2012–29471 Filed 12–5–12; 8:45 am]
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Correction: This notice was published
in the Federal Register on November 1,
2012 Volume 77, Number 215, page
66620. This notice is to announce the
extension of submission for potential
nominees.
Nominations should be sent, in
writing, and postmarked by December
21, 2012: Vernellia Johnson,
Management and Program Analyst,
Public Health Surveillance and
Informatics Program Office, Centers for
Disease Control and Prevention, Office
of Surveillance, Epidemiology and
Laboratory Services Century, 1600
Clifton Road NE., MS E–97, Atlanta, GA
30333 or via email to hft9@cdc.gov.
Telephone and facsimile submissions
cannot be accepted.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities for both CDC and
the Agency for Toxic Substances and
Disease Registry.
Dated: November 30, 2012.
Cathy Ramadei,
Acting Director, Management Analysis and
Services Office, Centers for Disease Control
and Prevention (CDC).
[FR Doc. 2012–29478 Filed 12–5–12; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2012–D–1086]
Compliance Guidance for Small
Business Entities on Labeling and
Effectiveness Testing; Sunscreen Drug
Products for Over-the-Counter Human
Use; Notice of Availability
AGENCY:
Food and Drug Administration,
HHS.
mstockstill on DSK4VPTVN1PROD with
ACTION:
Notice.
The Food and Drug
Administration (FDA) is announcing the
availability of a compliance guidance
for small business entities entitled
‘‘Labeling and Effectiveness Testing:
SUMMARY:
VerDate Mar<15>2010
16:42 Dec 05, 2012
Jkt 229001
PO 00000
Frm 00056
Fmt 4703
Sfmt 4703
Sunscreen Drug Products for Over-theCounter Human Use; Small Entity
Compliance Guide.’’ This guidance is
intended to help small businesses
understand and comply with the
requirements of the final rule addressing
labeling and effectiveness testing
requirements for over-the counter (OTC)
sunscreen drug products. The guidance
describes the requirements of the final
rule in plain language and provides
answers to common questions on how
to comply with the rule. This guidance
was prepared in accordance with the
Small Business Regulatory Enforcement
Fairness Act.
DATES: Submit either electronic or
written comments on Agency guidances
at any time.
ADDRESSES: Submit written requests for
single copies of this guidance to the
Division of Drug Information, Center for
Drug Evaluation and Research, Food
and Drug Administration, 10903 New
Hampshire Ave., Bldg. 51, Rm. 2201,
Silver Spring, MD 20993–0002. Send
one self-addressed adhesive label to
assist that office in processing your
requests. See the SUPPLEMENTARY
INFORMATION section for electronic
access to the guidance document.
Submit electronic comments on the
guidance to https://www.regulations.gov.
Submit written comments to the
Division of Dockets Management (HFA–
305), Food and Drug Administration,
5630 Fishers Lane, Rm. 1061, Rockville,
MD 20852.
FOR FURTHER INFORMATION CONTACT:
Reynold Tan, Center for Drug
Evaluation and Research, Food and
Drug Administration, 10903 New
Hampshire Ave., Bldg. 22, Rm. 5493,
Silver Spring, MD 20993–0002, 301–
796–1009.
SUPPLEMENTARY INFORMATION:
I. Background
FDA is announcing the availability of
a compliance guidance for small
business entities entitled ‘‘Labeling and
Effectiveness Testing: Sunscreen Drug
Products for Over-the-Counter Human
Use; Small Entity Compliance Guide.’’
This guidance summarizes the June 17,
2011, final rule (76 FR 35620) regarding
labeling and testing requirements for
OTC sunscreen drug products. Under
the 2011 sunscreen final rule, required
and permitted labeling is based upon
the results of effectiveness testing. The
effectiveness testing consists of a sun
protection factor (SPF) Test and a Broad
Spectrum (ultraviolet A (UVA) and
ultraviolet B (UVB) protection) Test. In
addition, a test demonstrating water
resistance that accompanies the SPF
Test to ensure retention of SPF
E:\FR\FM\06DEN1.SGM
06DEN1
]]>Agencies
[Federal Register Volume 77, Number 235 (Thursday, December 6, 2012)]
[Notices]
[Pages 72867-72868]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2012-29474]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[30Day-13-0214]
Agency Forms Undergoing Paperwork Reduction Act Review
The Centers for Disease Control and Prevention (CDC) publishes a
list of information collection requests under review by the Office of
Management and Budget (OMB) in compliance with the Paperwork Reduction
Act (44 U.S.C. Chapter 35). To request a copy of these requests, call
(404) 639-7570 or send an email to omb@cdc.gov. Send written comments
to CDC Desk Officer, Office of Management and Budget, Washington, DC or
by fax to (202) 395-5806. Written comments should be received within 30
days of this notice.
Proposed Project
National Health Interview Survey (NHIS), (OMB No. 0920-0214
expiration 08/31/2014)--Revision--National Center for Health Statistics
(NCHS), Centers for Disease Control and Prevention (CDC).
Background and Brief Description
Section 306 of the Public Health Service (PHS) Act (42 U.S.C.
242k), as amended, authorizes that the Secretary of Health and Human
Services (DHHS), acting through NCHS, shall collect statistics on the
extent and nature of illness and disability of the population of the
United States.
The annual National Health Interview Survey is a major source of
general statistics on the health of the U.S. population and has been in
the field continuously since 1957. Clearance is sought for three years,
to collect data for 2013, 2014, and 2015. This voluntary household-
based survey collects demographic and health-related information on a
nationally representative sample of persons and households throughout
the country. Information is collected using computer assisted personal
interviews (CAPI). A core set of data is collected each year while
sponsored supplements vary from year to year. For 2013, there are
supplementary questions on cancer screening, asthma, immune
suppression, hepatitis, epilepsy, HIV testing, neighborhood
characteristics, financial worries, sleep issues, and sexual identity.
Cases in a 5,000 case test were randomly assigned to receive
questions on HIV testing, neighborhood characteristics, financial
worries, sleep issues, and sexual identity in either CAPI or ACASI.
Prevalence estimates for the sexual identity questions were compared by
mode of administration. Since a documented advantage of ACASI is the
enhanced level of privacy it affords, we anticipated higher prevalence
estimates from this mode of administration. Estimates were similar for
the two modes of administration. Therefore, the questions will be
administered in CAPI, the more cost efficient mode.
In accordance with the 1995 initiative to increase the integration
of surveys within the Department of Health and Human Services,
respondents to the NHIS serve as the sampling frame for the Medical
Expenditure Panel Survey conducted by the Agency for Healthcare
Research and Quality. The NHIS has long been used by government,
university, and private researchers to evaluate both general health and
specific issues, such as cancer, diabetes, and access to health care.
It is a leading source of data for the Congressionally-mandated
``Health US'' and related publications, as well as the single most
important source of statistics to track progress toward the National
Health Promotion and Disease Prevention Objectives.
There is no cost to the respondents other than their time. As shown
below, the estimated overall average annual burden for the 2013, 2014,
and 2015 surveys is 57,099 hours.
Annualized Burden Table
----------------------------------------------------------------------------------------------------------------
Average
Number of Number of burden per
Questionnaire (respondent) respondents responses per respondent in
respondent hours
----------------------------------------------------------------------------------------------------------------
Screener Questionnaire.......................................... 12,000 1 5/60
Family Core (adult family member)............................... 55,000 1 23/60
Adult Core (sample adult)....................................... 44,000 1 15/60
Child Core (adult family member)................................ 17,000 1 10/60
Child/Teen Record Check (medical provider)...................... 10,000 1 5/60
Supplements (adult family member)............................... 60,000 1 12/60
Sexual Identity Module (adult family member).................... 44,000 1 4/60
Multi-mode study (adult family member).......................... 5,000 1 30/60
Reinterview Survey.............................................. 5,000 1 5/60
Sample Frame Test (adult family member)......................... 5,000 1 30/60
----------------------------------------------------------------------------------------------------------------
[[Page 72868]]
Kimberly S. Lane,
Deputy Director, Office of Scientific Integrity, Office of the
Associate Director for Science, Office of the Director, Centers for
Disease Control and Prevention.
[FR Doc. 2012-29474 Filed 12-5-12; 8:45 am]
BILLING CODE 4163-18-P
